반려동물용 스테로이드 시장 규모, 점유율, 성장 분석 : 제품 유형별, 제제 유형별, 동물 종류별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Steroids For Pets Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.01 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global steroids for pets market is primarily driven by the increasing prevalence of chronic inflammatory and immune-mediated conditions in companion animals, coupled with pet owners' growing willingness to invest in veterinary care. This sector includes corticosteroids used for inflammation control, allergies, and autoimmune disorders, providing rapid relief and improving pets' quality of life while fostering consistent prescription demand. The market has evolved from occasional off-label usage to standardized formulations, enhanced generic availability, and expanding online retail avenues. Key growth factors include better access to these medications, shifts in treatment paradigms, and the rise of pet insurance. AI technologies are enhancing safety monitoring through predictive analytics and real-time data analysis, thus improving treatment efficiency and increasing market confidence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Steroids For Pets market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Steroids For Pets Market Segments Analysis

Global steroids for pets market is segmented by product type, formulation type, animal type, end user and region. Based on product type, the market is segmented into Anabolic Steroids and Corticosteroids. Based on formulation type, the market is segmented into Tablets, Liquid Solutions and Powdered Form. Based on animal type, the market is segmented into Dogs, Cats and Others. Based on end user, the market is segmented into Veterinary Clinics, Pet Owners and Pet Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Steroids For Pets Market

The rising awareness among pet owners regarding chronic inflammatory and endocrine disorders has resulted in an increase in veterinary visits and a growing acceptance of pharmacological treatments, which bolsters the demand for steroid therapies. Initiatives aimed at educating pet owners, active online communities, and enhanced communication from veterinarians have facilitated better recognition of symptoms and the associated benefits of steroid treatments. As diagnostic methods advance and communication improves, pet owners tend to adhere more closely to prescribed steroid regimens, ultimately leading to greater market penetration and wider acceptance of steroid products within the realm of companion animal healthcare.

Restraints in the Global Steroids For Pets Market

The Global Steroids for Pets market faces significant challenges due to stringent regulatory frameworks and heightened safety concerns surrounding steroid use in animals. These factors add complexity and elevate costs associated with product approval and post-market monitoring, which can hinder the timely introduction of new formulations. Additionally, apprehensions regarding potential adverse effects, risks linked to prolonged usage, and the possibility of misuse necessitate more rigorous labeling and oversight. Consequently, both veterinarians and pet owners tend to be more cautious in prescribing and administering steroids. This cautious approach can limit the routine use of such products, restrict the variety available in the market, and deter manufacturers from attempting to enter this segment, even in the presence of obvious clinical demand.

Market Trends of the Global Steroids For Pets Market

The Global Steroids for Pets market is witnessing a significant shift as pet owners increasingly treat their animals as integral family members, fueling a demand for personalized treatment options. This trend emphasizes the importance of individualized care, with owners seeking transparent communication regarding the benefits and administration of steroid therapies. There is a growing preference for formulations that promote wellness and minimize stress while enhancing the quality of life for pets. Consequently, manufacturers are responding by developing user-friendly dosing solutions, comprehensive educational resources, and adherence programs, positioning themselves to meet owner expectations and reinforce brand loyalty, ultimately fostering a premium market presence.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Steroids for Pets Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Anabolic Steroids
  • Injectable Anabolics
  • Oral Anabolics
• Corticosteroids
  • Topical Corticosteroids
  • Injectable Corticosteroids

Global Steroids for Pets Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Tablets
• Liquid Solutions
• Powdered Form

Global Steroids for Pets Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Dogs
• Cats
• Others

Global Steroids for Pets Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Pet Owners
• Pet Pharmacies

Global Steroids for Pets Market Size & CAGR (2026-2033)

• North America (Product Type, Formulation Type, Animal Type, End User)
  • US
  • Canada
• Europe (Product Type, Formulation Type, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Formulation Type, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Formulation Type, Animal Type, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Formulation Type, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VytoMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetMed Express
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetEmergencies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetSage
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arecibo Animal Hospital
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetTech Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetBiologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Animal Health International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Veterinary Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScanVet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Royal Canin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PetIQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations